Removal of elevated circulating angiopoietin-2 by plasma exchange--a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease.

MLA

Lovric, Svjetlana, et al. “Removal of Elevated Circulating Angiopoietin-2 by Plasma Exchange--a Pilot Study in Critically Ill Patients with Thrombotic Microangiopathy and Anti-Glomerular Basement Membrane Disease.” Thrombosis and Haemostasis, vol. 104, no. 5, Nov. 2010, pp. 1038–43. EBSCOhost, https://doi.org/10.1160/TH10-02-0138.

APA

Lovric, S., Lukasz, A., Hafer, C., Kielstein, J. T., Haubitz, M., Haller, H., & Kümpers, P. (2010). Removal of elevated circulating angiopoietin-2 by plasma exchange--a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease. Thrombosis and Haemostasis, 104(5), 1038–1043. https://doi.org/10.1160/TH10-02-0138

Chicago

Lovric, Svjetlana, Alexander Lukasz, Carsten Hafer, Jan T Kielstein, Marion Haubitz, Hermann Haller, and Philipp Kümpers. 2010. “Removal of Elevated Circulating Angiopoietin-2 by Plasma Exchange--a Pilot Study in Critically Ill Patients with Thrombotic Microangiopathy and Anti-Glomerular Basement Membrane Disease.” Thrombosis and Haemostasis 104 (5): 1038–43. doi:10.1160/TH10-02-0138.